Is a complete BNR research report available?

No complete published report is available for Burning Rock Biotech Limited (BNR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Burning Rock Biotech Limited (BNR)

NASDAQ: BNR · USD

$12.2

+0.30 (+2.5%)· Recorded snapshot

Market cap	128.3M
Revenue (ttm)	73.7M
Net income (ttm)	-10M
EPS (ttm)	-$0.95
Shares out	10.5M
Volume	17,317
Beta	1.29

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 73.7M
Net income (ttm): -10M
EPS (ttm): -$0.95
Market cap: 128.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Metric	Value
Amount currency	USD
CIK code	0001792267
Company name	Burning Rock Biotech Limited
Country	China
Country code	US
CUSIP number	12233L206
Earnings date	2026-11-19
Earnings time	bmo
Employees	667
Employees change	-7
Employees growth	-1.04%
Enterprise value	$73.6M
Exchange	NASDAQ
Financial currency	CNY
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
Industry	Diagnostics & Research
IPO date	2020-06-12
Is primary listing	Yes
Is SPAC	No
ISIN number	US12233L2060
Last 10-K release date	2026-04-28
Last earnings date	2026-09-10
Last refreshed	2026-10-28
Last stock split date	2024-05-15
Last stock split type	Reverse
Market cap	$128.3M
Market cap category	Micro-Cap
Next earnings date	2026-11-19
Options	No
Price	$12.17
Price currency	USD
Sector	Healthcare
SIC code	8071
Stock price date	2026-10-28
Symbol	BNR
Website	https://www.brbiotech.com

Metric

Value

Amount currency

USD

CIK code

0001792267

Company name

Burning Rock Biotech Limited

Country

China

Country code

CUSIP number

12233L206

Earnings date

2026-11-19

Earnings time

bmo

Employees

667

Employees change

-7

Employees growth

-1.04%

Enterprise value

$73.6M

Exchange

NASDAQ

Financial currency

CNY

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2014

Industry

Diagnostics & Research

IPO date

2020-06-12

Is primary listing

Yes

Is SPAC

ISIN number

US12233L2060

Last 10-K release date

2026-04-28

Last earnings date

2026-09-10

Last refreshed

2026-10-28

Last stock split date

2024-05-15

Last stock split type

Reverse

Market cap

$128.3M

Market cap category

Micro-Cap

Next earnings date

2026-11-19

Options

Price

$12.17

Price currency

USD

Sector

Healthcare

SIC code

8071

Stock price date

2026-10-28

Symbol

BNR

Website

https://www.brbiotech.com

Metric	Value
Earnings yield	-7.77%
EV/Sales	0.96x
FCF / EV yield	-3.72%
FCF yield	-2.09%
Industry forward P/E	30.71x
Industry P/E	50.2x
P/B ratio	1.76x
P/S ratio	1.7x
Price / tangible book value	1.71x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-7.77%

EV/Sales

0.96x

FCF / EV yield

-3.72%

FCF yield

-2.09%

Industry forward P/E

30.71x

Industry P/E

50.2x

P/B ratio

1.76x

P/S ratio

1.7x

Price / tangible book value

1.71x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
EBIT margin	-12.99%
EBITDA margin	-11.64%
Gross margin	74.55%
Operating margin	-12.99%
Pretax margin	-13.27%
Profit margin	-13.59%
Profit per employee	$-15,014
Revenue per employee	$110,497
ROA	-5.16%
ROA (5Y)	-21.73%
ROCE	-12.2%
ROE	-12.82%
ROE (5Y)	-46.23%
ROIC	-7.09%
SBC / revenue	2.77%
Tax / revenue	0.32%

Metric

Value

EBIT margin

-12.99%

EBITDA margin

-11.64%

Gross margin

74.55%

Operating margin

-12.99%

Pretax margin

-13.27%

Profit margin

-13.59%

Profit per employee

$-15,014

Revenue per employee

$110,497

ROA

-5.16%

ROA (5Y)

-21.73%

ROCE

-12.2%

ROE

-12.82%

ROE (5Y)

-46.23%

ROIC

-7.09%

SBC / revenue

2.77%

Tax / revenue

0.32%

Metric	Value
EPS growth years	3
Gross profit growth	-3.5%
Gross profit growth (Q)	-9.52%
Gross profit growth 3Y	-3.01%
Gross profit growth 5Y	0.84%
Net income growth years	3
Revenue growth	-6.65%
Revenue growth (Q)	-9.28%
Revenue growth (QoQ)	24.85%
Revenue growth 3Y	-5.09%
Revenue growth 5Y	0.45%
Revenue growth years	1

Metric

Value

EPS growth years

Gross profit growth

-3.5%

Gross profit growth (Q)

-9.52%

Gross profit growth 3Y

-3.01%

Gross profit growth 5Y

0.84%

Net income growth years

Revenue growth

-6.65%

Revenue growth (Q)

-9.28%

Revenue growth (QoQ)

24.85%

Revenue growth 3Y

-5.09%

Revenue growth 5Y

0.45%

Revenue growth years

Metric	Value
Capital expenditures	$-787,370
Depreciation and amortization	$1M
EBIT	$-9.6M
EBITDA	$-8.6M
EPS	$-0.95
FCF per share	$-0.25
Financing cash flow	$-29,443
Free cash flow	$-2.6M
Free cash flow minus SBC	$-4.7M
Gross profit	$54.9M
Income taxes	$236,574
Investing cash flow	$-869,744
Net borrowing	$285,007
Net cash flow	$-5.3M
Net income	$-10M
Operating cash flow minus SBC	$-3.9M
Operating income	$-9.6M
Revenue	$73.7M
Stock-based compensation	$2M

Metric

Value

Capital expenditures

$-787,370

Depreciation and amortization

$1M

EBIT

$-9.6M

EBITDA

$-8.6M

EPS

$-0.95

FCF per share

$-0.25

Financing cash flow

$-29,443

Free cash flow

$-2.6M

Free cash flow minus SBC

$-4.7M

Gross profit

$54.9M

Income taxes

$236,574

Investing cash flow

$-869,744

Net borrowing

$285,007

Net cash flow

$-5.3M

Net income

$-10M

Operating cash flow minus SBC

$-3.9M

Operating income

$-9.6M

Revenue

$73.7M

Stock-based compensation

$2M

Metric	Value
Altman Z-Score	-4.18
Book value per share	$6.74
Debt / equity	0.09
Interest coverage	-1,083.57
Long-term assets	$10.9M
Long-term liabilities	$4.7M
Net cash (debt)	$54.7M
Net cash / market cap	43.71%
Net cash growth	-10.13%
Net debt / equity	-0.75
Piotroski F-Score	4
Property, plant and equipment	$11.7M
Shareholders' equity	$73.2M
Tangible book value	$73.1M
Tangible book value per share	$6.73
Total assets	$110.5M
Total cash	$61.4M
Total debt	$6.6M
Total liabilities	$37.3M
WACC	10.8%

Metric

Value

Altman Z-Score

-4.18

Book value per share

$6.74

Debt / equity

0.09

Interest coverage

-1,083.57

Long-term assets

$10.9M

Long-term liabilities

$4.7M

Net cash (debt)

$54.7M

Net cash / market cap

43.71%

Net cash growth

-10.13%

Net debt / equity

-0.75

Piotroski F-Score

Property, plant and equipment

$11.7M

Shareholders' equity

$73.2M

Tangible book value

$73.1M

Tangible book value per share

$6.73

Total assets

$110.5M

Total cash

$61.4M

Total debt

$6.6M

Total liabilities

$37.3M

WACC

10.8%

Metric	Value
Asset turnover	0.64
Current assets	$99.6M
Current liabilities	$32.6M
Current ratio	3.05
Inventory turnover	2.77
Net working capital	$7.5M
Quick ratio	2.76
Working capital	$65.7M
Working capital turnover	0.15

Metric

Value

Asset turnover

0.64

Current assets

$99.6M

Current liabilities

$32.6M

Current ratio

3.05

Inventory turnover

2.77

Net working capital

$7.5M

Quick ratio

2.76

Working capital

$65.7M

Working capital turnover

0.15

Metric	Value
Buyback yield / dilution	-0.43%
Dividend yield	0%
Shareholder yield	-0.43%

Metric

Value

Buyback yield / dilution

-0.43%

Dividend yield

Shareholder yield

-0.43%

Metric	Value
150-day SMA	$12.96
1D price change	2.49%
1M price change	-33.84%
1M total return	-33.84%
1W price change	-2.8%
1W total return	-2.8%
1Y price change	5.17%
1Y return CAGR	5.18%
1Y total return	5.17%
20-day SMA	$14.10
200-day SMA	$16.60
3M price change	30.9%
3M total return	30.9%
3Y price change	16.64%
3Y return CAGR	5.26%
3Y total return	16.64%
50-day SMA	$13.19
50-day SMA vs 200-day SMA	50under200
52-week high	$41.72
52-week high date	2026-01-22
52-week low	$6.79
52-week low date	2026-06-17
5Y price change	-91.38%
5Y return CAGR	-38.76%
5Y total return	-91.38%
6M price change	-35.44%
6M total return	-35.44%
All-time high	$397.50
All-time high date	2021-02-22
All-time low	$2.18
All-time low date	2025-05-05
Average true range (ATR)	$1.63
Average volume	25.6K
Beta (1Y)	2.92
Beta (2Y)	2.25
Beta (5Y)	1.29
Change from 52-week high	-70.84%
Change from 52-week low	79.16%
Change from all-time high	-96.9%
Change from all-time low	464.45%
Change from open	5.87%
Day's gap	-3.2%
Dollar volume	$210,661
High price	$12.42
Low price	$11.49
Monthly RSI	46.41
Open price	$11.49
Position in 52-week range	72.58%
Previous close	$11.87
Price vs 150-day SMA	-5.05%
Price vs 20-day SMA	-12.74%
Price vs 200-day SMA	-25.89%
Price vs 50-day SMA	-6.7%
Relative volume	0.68
Return from IPO open	-94.79%
Return from IPO price	-28.06%
RSI	43.67
Sharpe ratio	0.55
Sharpe ratio (3Y)	0.57
Sharpe ratio (5Y)	-0.06
Sortino ratio	0.9
Sortino ratio (3Y)	0.97
Sortino ratio (5Y)	-0.04
Volume	17.3K
Weekly RSI	46.59
YTD price change	-38.93%
YTD total return	-38.93%

Metric

Value

150-day SMA

$12.96

1D price change

2.49%

1M price change

-33.84%

1M total return

-33.84%

1W price change

-2.8%

1W total return

-2.8%

1Y price change

5.17%

1Y return CAGR

5.18%

1Y total return

5.17%

20-day SMA

$14.10

200-day SMA

$16.60

3M price change

30.9%

3M total return

30.9%

3Y price change

16.64%

3Y return CAGR

5.26%

3Y total return

16.64%

50-day SMA

$13.19

50-day SMA vs 200-day SMA

50under200

52-week high

$41.72

52-week high date

2026-01-22

52-week low

$6.79

52-week low date

2026-06-17

5Y price change

-91.38%

5Y return CAGR

-38.76%

5Y total return

-91.38%

6M price change

-35.44%

6M total return

-35.44%

All-time high

$397.50

All-time high date

2021-02-22

All-time low

$2.18

All-time low date

2025-05-05

Average true range (ATR)

$1.63

Average volume

25.6K

Beta (1Y)

2.92

Beta (2Y)

2.25

Beta (5Y)

1.29

Change from 52-week high

-70.84%

Change from 52-week low

79.16%

Change from all-time high

-96.9%

Change from all-time low

464.45%

Change from open

5.87%

Day's gap

-3.2%

Dollar volume

$210,661

High price

$12.42

Low price

$11.49

Monthly RSI

46.41

Open price

$11.49

Position in 52-week range

72.58%

Previous close

$11.87

Price vs 150-day SMA

-5.05%

Price vs 20-day SMA

-12.74%

Price vs 200-day SMA

-25.89%

Price vs 50-day SMA

-6.7%

Relative volume

0.68

Return from IPO open

-94.79%

Return from IPO price

-28.06%

RSI

43.67

Sharpe ratio

0.55

Sharpe ratio (3Y)

0.57

Sharpe ratio (5Y)

-0.06

Sortino ratio

0.9

Sortino ratio (3Y)

0.97

Sortino ratio (5Y)

-0.04

Volume

17.3K

Weekly RSI

46.59

YTD price change

-38.93%

YTD total return

-38.93%

Metric	Value
Float	3.3M
Float percentage	31.46%
Shares change (QoQ)	3.24%
Shares change (YoY)	0.43%
Shares held by insiders	30.92%
Shares held by institutions	11.03%
Shares outstanding	10.5M
Short % of shares	0.58%
Short ratio	0.7 days

Metric

Value

Float

3.3M

Float percentage

31.46%

Shares change (QoQ)

3.24%

Shares change (YoY)

0.43%

Shares held by insiders

30.92%

Shares held by institutions

11.03%

Shares outstanding

10.5M

Short % of shares

0.58%

Short ratio

0.7 days

Burning Rock Biotech Limited (BNR)

Price

Financial snapshot

Fair-value bridge

Latest news · BNR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BNR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BNR

Frequently asked questions